68Ga-FAPI
PDAC
PET
cancer imaging
fibroblast activation protein
pancreatic ductal adenocarcinoma
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
received:
07
02
2023
revised:
27
09
2023
medline:
4
12
2023
pubmed:
17
11
2023
entrez:
16
11
2023
Statut:
epublish
Résumé
The fibroblast activation protein (FAP) is highly expressed on carcinoma-associated fibroblasts in the stroma of pancreatic cancer and thus is a promising target for imaging and therapy. Preliminary data on PET imaging with radiolabeled FAP inhibitors (FAPIs) demonstrate superior tumor detection. Here we assess the accuracy of FAP-directed PET in patients with pancreatic cancer.
Identifiants
pubmed: 37973185
pii: jnumed.122.264827
doi: 10.2967/jnumed.122.264827
doi:
Substances chimiques
Gallium Radioisotopes
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Quinolines
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1910-1917Informations de copyright
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.